CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue2,440.1951,911.424648.382-
Cost of Revenue26,038.96515,436.7355,888.6591,255.535
Gross Profit-23,598.77-13,525.311-5,240.277-1,255.535
Operating Expenses
Research Development----
Selling General and Administrative8,964.0466,459.7473,613.4161,391.638
Non Recurring----
Others----
Total Operating Expenses35,003.01121,896.4829,502.0752,647.173
Operating Income or Loss-32,562.816-19,985.058-8,853.693-2,647.173
Income from Continuing Operations
Total Other Income/Expenses Net141.204-13.6172.954106.688
Earnings Before Interest and Taxes-32,562.816-19,985.058-8,853.693-2,647.173
Interest Expense-14.087-4.401-2.44-24.021
Income Before Tax-32,421.612-19,998.675-8,850.739-2,540.485
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-32,421.612-19,998.675-8,850.739-2,540.485
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-32,421.612-19,998.675-8,850.739-2,540.485
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-32,421.612-19,998.675-8,850.739-2,540.485